Home > Healthcare > Pharmaceuticals > Finished Drug Form > Barbiturate Drugs Market

Barbiturate Drugs Market Share

  • Report ID: GMI8668
  • Published Date: Mar 2024
  • Report Format: PDF

Barbiturate Drugs Market Share

The barbiturate drugs industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced devices based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Barbiturate Drugs Market Companies

Some of the eminent market participants operating in the barbiturate drugs industry include:

  • Abbott Laboratories
  • AbbVie Inc.                        
  • Akorn, Inc.                        
  • Centurion Healthcare Private Limited                             
  • Ethypharm                        
  • GSK plc.                            
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson                       
  • Merck & Co., Inc.                         
  • Novartis AG                       
  • Par Pharmaceutical Companies, Inc.                             
  • Pfizer Inc.                          
  • Samarth Life Sciences Pvt Ltd.                           
  • Sun Pharmaceutical Industries Ltd.                     
  • Teva Pharmaceutical Industries Limited
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Barbiturate drugs market size was USD 472.9 million in 2023 and is expected to register 3% CAGR from 2024-2032 owing to the surge in demand for innovative treatments and therapies to address the rising incidence of neurological disorders worldwide.

The long-acting barbiturate segment recorded USD 200.4 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their ability to provide sustained drug release over an extended period ensuring prolonged therapeutic effects.

North America barbiturate drugs industry reached USD 191.6 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a well-developed healthcare infrastructure with modern facilities and sophisticated medical technology in the region.

Johnson & Johnson, Merck & Co., Inc., Novartis AG, Par Pharmaceutical Companies, Inc., Pfizer Inc., Samarth Life Sciences Pvt Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Limited, are some of the major barbiturate drugs companies worldwide.

Barbiturate Drugs Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 219
  • Countries covered: 22
  • Pages: 190
 Download Free Sample